Ubs Group Ag Age X Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$0.33 - $0.74 $126 - $283
383 Added 162.98%
618 $0
Q3 2023

Nov 09, 2023
SELL
$0.67 - $0.85 $3,642 - $4,620
-5,436 Reduced 95.86%
235 $0
Q2 2023

Aug 11, 2023
BUY
$0.45 - $0.89 $2,536 - $5,016
5,636 Added 16102.86%
5,671 $5,000
Q1 2023

May 12, 2023
SELL
$0.56 - $0.8 $7,541 - $10,773
-13,467 Reduced 99.74%
35 $0
Q4 2022

Feb 08, 2023
BUY
$0.54 - $0.68 $7,272 - $9,157
13,467 Added 38477.14%
13,502 $7,000
Q1 2022

May 16, 2022
SELL
$0.65 - $1.2 $10,204 - $18,838
-15,699 Reduced 99.78%
35 $0
Q4 2021

Feb 14, 2022
BUY
$0.53 - $1.09 $8,299 - $17,068
15,659 Added 20878.67%
15,734 $17,000
Q3 2021

Nov 15, 2021
BUY
$0.93 - $1.54 $37 - $61
40 Added 114.29%
75 $0
Q2 2021

Aug 13, 2021
SELL
$1.14 - $1.77 $2,259 - $3,508
-1,982 Reduced 98.26%
35 $0
Q1 2021

May 12, 2021
SELL
$1.56 - $2.7 $7,441 - $12,879
-4,770 Reduced 70.28%
2,017 $4,000
Q4 2020

Feb 11, 2021
SELL
$0.8 - $2.56 $11,494 - $36,782
-14,368 Reduced 67.92%
6,787 $10,000
Q3 2020

Nov 12, 2020
BUY
$0.79 - $1.52 $10,849 - $20,875
13,734 Added 185.07%
21,155 $17,000
Q2 2020

Jul 31, 2020
SELL
$0.68 - $1.13 $4,734 - $7,868
-6,963 Reduced 48.41%
7,421 $7,000
Q1 2020

May 01, 2020
SELL
$0.78 - $1.95 $13,841 - $34,604
-17,746 Reduced 55.23%
14,384 $13,000
Q4 2019

Feb 14, 2020
BUY
$1.25 - $1.82 $15,398 - $22,420
12,319 Added 62.18%
32,130 $59,000
Q3 2019

Nov 14, 2019
BUY
$1.96 - $3.38 $21,440 - $36,973
10,939 Added 123.3%
19,811 $39,000
Q2 2019

Aug 14, 2019
BUY
$2.58 - $4.92 $13,913 - $26,533
5,393 Added 155.02%
8,872 $33,000
Q1 2019

May 14, 2019
SELL
$3.0 - $4.85 $2,151 - $3,477
-717 Reduced 17.09%
3,479 $14,000
Q4 2018

Feb 14, 2019
BUY
$2.49 - $5.5 $10,448 - $23,078
4,196 New
4,196 $12,000

Others Institutions Holding AGE

# of Institutions
1
Shares Held
1K
Call Options Held
0
Put Options Held
0
View Full List

About AgeX Therapeutics, Inc.

AGE Quotes by TradingView
  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email